Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
543 News Items found
Dr. Michel Sadelain, Director of the Center for Cell Engineering, Sloan Kettering Institute.
Disrupting a Single Gene Could Improve CAR T Cell Immunotherapy, New Study Shows

Learn how disrupting a gene called SUV39H1 could make CAR T cells more powerful.
MSK Awards & Appointments January 2023
MSK Awards & Appointments October 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023

New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Article
A research working in an MSK lab
MSK Research Highlights, October 19, 2023

New MSK research examines how diabetes may speed the growth of multiple myeloma; analyzes the increasing number of patients who are benefiting from precision oncology; and highlights the unexpected role of the integrated stress response in response to genomic instability in mitochondrial DNA.
Researchers Russell Kunes, Thomas Walle, and Dana Pe'er
MSK Researchers Develop New Open-Source Method To Improve Decoding of Single-Cell Data

MSK researchers have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data — and made it freely available to researchers around the world.
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.
MSK Awards & Appointments January 2023
MSK Awards & Appointments September 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Dr. Teddy Yewdell presenting at the MSK Postdoc Slam and in front of the sign of his new employer, Genentech.
Training the Next Generation of Scientists: Meet 3 Remarkable MSK Alumni

At MSK, our goal is not just to train the scientists of tomorrow, but the scientific leaders.
Michel Sadelain, MD, PhD
Memorial Sloan Kettering Cancer Center Physician-Scientist Michel Sadelain Awarded 2024 Breakthrough Prize in Life Sciences

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for Cell Engineering, and Stephen and Barbara Friedman Chair, has been awarded the 2024 Breakthrough Prize in Life Sciences.
Three GSK students in a classroom
Gerstner Sloan Kettering Graduate Students Receive 2023-2024 Fellowships

Seven GSK PhD students were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).